Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
You can purchase shares of Leap Therapeutics (NASDAQ:LPTX) through any online brokerage.
Other companies in Leap Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Invizyne Technologies (NASDAQ:IZTC), Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY) and Atossa Therapeutics (NASDAQ:ATOS).
Leap Therapeutics has a consensus price target of $10.40.
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $2.5 last updated January 21, 2025 at 7:37 PM EST.
There are no upcoming dividends for Leap Therapeutics.
Leap Therapeutics’s Q4 earnings are confirmed for Monday, March 17, 2025.
There is no upcoming split for Leap Therapeutics.
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.